Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle C Cuneo

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Role of Stereotactic Body Radiation Therapy in Oligometastatic SarcomaKyle C Cuneo
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Growing Evidence Supports the Use of Radiation Therapy in Unresectable Intrahepatic CholangiocarcinomaKyle C Cuneo, Theodore S Lawrence
Surgical Oncology Clinics of North America|May 14, 2023
Advances in Radiation Therapy for Primary Liver CancerKyle C Cuneo, Daniel J Herr
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Drug-Radiotherapy Combination Trial Developments-LetterJoseph R Evans, Kyle C Cuneo, Theodore S Lawrence
Anti-Cancer Drugs|February 1, 2007
Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasisKyle C Cuneo, Allie Fu, Katherine L Osusky, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2019
In Reply to Slovak et alWilliam C Jackson, Kyle C Cuneo, Theodore S Lawrence, et al.
Pharmacology & Therapeutics|July 25, 2015
EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selectionKyle C Cuneo, Mukesh K Nyati, Dipankar Ray, et al.
Journal of Proteome Research|March 2, 2018
Circulating Microvesicles from Pancreatic Cancer Accelerate the Migration and Proliferation of PANC-1 CellsMingrui An, Jianhui Zhu, Jing Wu, et al.
Analytical Chemistry|June 20, 2018
High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome MetabolomicsXian Luo, Mingrui An, Kyle C Cuneo, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Inducing Oncoprotein Degradation to Improve Targeted Cancer TherapyDipankar Ray, Kyle C Cuneo, Alnawaz Rehemtulla, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Role of Stereotactic Body Radiation Therapy in Oligometastatic SarcomaKyle C Cuneo
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Growing Evidence Supports the Use of Radiation Therapy in Unresectable Intrahepatic CholangiocarcinomaKyle C Cuneo, Theodore S Lawrence
Surgical Oncology Clinics of North America|May 14, 2023
Advances in Radiation Therapy for Primary Liver CancerKyle C Cuneo, Daniel J Herr
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Drug-Radiotherapy Combination Trial Developments-LetterJoseph R Evans, Kyle C Cuneo, Theodore S Lawrence
Anti-Cancer Drugs|February 1, 2007
Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasisKyle C Cuneo, Allie Fu, Katherine L Osusky, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2019
In Reply to Slovak et alWilliam C Jackson, Kyle C Cuneo, Theodore S Lawrence, et al.
Pharmacology & Therapeutics|July 25, 2015
EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selectionKyle C Cuneo, Mukesh K Nyati, Dipankar Ray, et al.
Journal of Proteome Research|March 2, 2018
Circulating Microvesicles from Pancreatic Cancer Accelerate the Migration and Proliferation of PANC-1 CellsMingrui An, Jianhui Zhu, Jing Wu, et al.
Analytical Chemistry|June 20, 2018
High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome MetabolomicsXian Luo, Mingrui An, Kyle C Cuneo, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Inducing Oncoprotein Degradation to Improve Targeted Cancer TherapyDipankar Ray, Kyle C Cuneo, Alnawaz Rehemtulla, et al.
Pageof 8